Member Info for Notmyjob

A growing cash pile of around £30M with further deal said to be announced in a red hot sector and expected dividend deals or similar on Imutex should Be incentive enough to keep one’s monies in here.
Then we have the very real prospect of a bidding war between the likes of Google, Amazon, Apple, Fitbit or Samsung for access to our GHD database for their wearable technologies.
There’s a lot of dross on AIM, this ain’t one of them.

Oops. Bit slow on the uptake of the joke.
Lets hope the share price moves north a bit quicker!

It’s factual.

Looks like we’re hiring.
https://careers-hvivo.icims.com/jobs/search?ss=1&hashed=-435770388

I topped up Monday and again today. Currently ORPH is around 25% of my p/f now but I feel there aren’t too many days to wait before we have a good run north.

Nothing wrong in posting factual information to remind ourselves why we are invested in here and to help new investors.
Maybe we should date any articles we post?

Nice find!
Hopefully Evotec will be looking at using Nuvec to administer any successful C-19 antibody products on behalf of the Department of Defense. USA.

At 15:53 for 301 041 shares at 14p when the bid/ask was 18/18.4
Thoughts?

And one would hope that the company’s portfolio of drug discoveries has progressed since the share price was at the 100p mark.

Browsing the company’s website and you are met with:
“Creating the world’s most productive drug discovery engine.”
“Designing and creating best in class drug candidates.”
The share price may well get a boost next week, but if the company delivers on the above, who knows what the mcap will become.

I see the derampers are out today looking for a bargain basement entry.
Well researched investors know the time lines and July could well see a big rearate.

Only recently took a position in SNG but couldn’t resist the sub 40p price on offer this morning.

Haven’t got a Times subscription. What’s the detail in the story?

Quietly getting on with the business of producing oil and gas and making money.
At some point the market will take note, but in he mean time I shall continue to buy any dips.

Evening everybody. Unfortunately Link are selling off chunks in a couple of other pharma stocks that I’m in. It has given me the opportunity to top up but it’s equally as frustrating watching the share prices get beaten down...
Decided to take advantage of the whole Woodford/Link saga so after spending last night and most of this morning going through the RNS etc I decided to take the plunge here. How many shares do you think Link have left?

From the end of Year results:
2019 Highlights
§ Revenue up to $101.7m (2018:$92.9m) thanks to increased production volume in Ukraine, despite lower gas prices.
§ Profit before tax up to $30.4m (2018:$14.0m).
§ Cash generated from continuing operations up to $41.4m (2018:$37.3m).
§ Year end cash position of $20.6m (2018:$19.2m).
§ Final bond payment made February 2020, making the JKX Group debt free.
§ Average daily production up to 10,748boepd (2018:8,
§ In Ukraine, production up more than 50% to 5,584boepd (2018:3,677boepd) due to continued execution of development plan.
§ In Russia, well workover programme completed and average production maintained at 5,158boepd (2018:5,169boepd).

Plus the fundamentals of the company offer so much moving forward.
Final results in March 2020 were truly impressive.
Debt free
10 748 boepd equivalent
Mcap US$46M
Revenue US$102M
Cash US$21M

Read the latest RNS. That’s 60 seconds of my life I won’t get back.
Completely pointless.
You’d be better of applying for a gold exploration license yourself and heading to Oz with a spade.

And the 104 new samples?

Wow.
A vaccine before a test!